Pharmacokinetics and Leukocyte Responses of Recombinant Human Interleukin-10

被引:0
|
作者
Elaine Radwanski
Abhijit Chakraborty
Scott Van Wart
Richard D. Huhn
David L. Cutler
Melton B. Affrime
William J. Jusko
机构
[1] Schering-Plough Research Institute,Department of Pharmaceutics, School of Pharmacy
[2] University of Medicine and Dentistry of New Jersey,undefined
[3] Robert Wood Johnson Medical School,undefined
[4] State University of New York at Buffalo,undefined
来源
Pharmaceutical Research | 1998年 / 15卷
关键词
IL-10; cytokines; protein; immunosuppression; pharmacokinetics;
D O I
暂无
中图分类号
学科分类号
摘要
Purpose. To study the pharmacokinetics and ex vivo leukocyte responses of recombinant human IL-10 (rHuIL-10) following single SC and IV dosing.
引用
收藏
页码:1895 / 1901
页数:6
相关论文
共 50 条
  • [11] Interleukin-10 and interleukin-10 receptor in human osteoarthritic and healthy chondrocytes
    Iannone, F
    De Bari, C
    Dell'Accio, F
    Covelli, M
    Cantatore, FP
    Patella, V
    Lo Bianco, G
    Lapadula, G
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (02) : 139 - 146
  • [12] Effect of human recombinant interleukin-10 on cytokines in adjuvant arthritis rat
    Ren, Qiang
    Meng, Tao
    Lin, Chao
    Du, Changling
    Liu, Tao
    Wang, Jianming
    Liu, Mingting
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (05): : 5606 - 5610
  • [13] Interleukin-10 pharmacokinetics in intact and nephrectomized mice
    Chiu, PJS
    Radwanski, E
    Tetiloff, G
    Monge, A
    Swanson, SJ
    EUROPEAN CYTOKINE NETWORK, 1996, 7 (01) : 67 - 69
  • [14] Interleukin-10 and the interleukin-10 receptor
    Moore, KW
    Malefyt, RD
    Coffman, RL
    O'Garra, A
    ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 : 683 - 765
  • [15] Disposition of recombinant human interleukin-10 in subjects with various degrees of renal function
    Andersen, SR
    Lambrecht, LJ
    Swan, SK
    Cutler, DL
    Radwanski, E
    Affrime, MB
    Garaud, JJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (10): : 1015 - 1020
  • [16] CRYSTALLIZATION AND PRELIMINARY-X-RAY INVESTIGATION OF RECOMBINANT HUMAN INTERLEUKIN-10
    COOK, WJ
    WINDSOR, WT
    MURGOLO, NJ
    TINDALL, SH
    NAGABHUSHAN, TL
    WALTER, MR
    PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1995, 22 (02): : 187 - 190
  • [17] Inhibitory effect of interleukin-10 on human leukocyte interferon-α production by Sendai virus
    Zhao, XX
    Liao, MJ
    Rashidbaigi, A
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 1998, 4 (01) : 11 - 16
  • [18] In vivo changes of lymphocyte subpopulations and leukocyte surface markers by multiple doses of recombinant human interleukin-10 in inflammatory bowel disease.
    Dejaco, C
    Lichtenberger, C
    Reinisch, W
    Kuhn, I
    Tilg, H
    Gasche, C
    GASTROENTEROLOGY, 1998, 114 (04) : A961 - A961
  • [19] Endogenous mouse interleukin-10 is up-regulated by exogenously administered recombinant human interleukin-10, but does not contribute to the efficacy of the human protein in mouse models of endotoxemia
    Smith, SR
    Terminelli, C
    Denhardt, G
    Manfra, D
    Davies, L
    Narula, S
    IMMUNOPHARMACOLOGY, 1999, 41 (02): : 119 - 130
  • [20] Nuclease activity of human interleukin-10
    Dranitsyna, SM
    Kostanyan, IA
    Astapova, MV
    Surina, EA
    Lipkin, VM
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2002, 28 (01) : 74 - 76